As BIO 2026 approaches, companies preparing for partnering, financing, and commercialization discussions should consider the questions investors, strategic partners, and pharmaceutical companies are likely to ask.

BioNJ serves as a leading voice for New Jersey's life sciences ecosystem, bringing together biotechnology, pharmaceutical, medical technology, and research organizations to advance innovation, collaboration, and industry growth. LexStrat's membership reflects our commitment to supporting life sciences companies operating at the intersection of science, strategy, and commercialization.

LexStrat Law will attend the AI Agent Conference 2026 to stay at the forefront of agentic AI development and its responsible deployment in regulated markets.

LexStrat Law will attend the IAPP Global Summit 2026 in Washington, D.C., focusing on the integration of responsible AI governance and operational risk frameworks for innovation-driven businesses.

LexStrat Law will attend the BIO International Convention 2026 and looks forward to connecting with colleagues across the life sciences community.

Life Sciences Pennsylvania is a leading advocate for policy, innovation, and growth in the regional life sciences sector. LexStrat’s membership reflects our commitment to participating in that effort.

The firm established its professional office in the Greater Philadelphia region to support clients across life sciences and emerging technology markets.​

LexStrat was established to provide strategic legal advice to life sciences, pharmaceutical, technology and other innovation-driven companies operating in regulated and tech-enabled sectors.